Abstract
The frequency of squamous cell skin carcinoma in organ transplant patients is around 100-fold higher than normal. This dramatic example of therapy-related cancer reflects exposure to sunlight and to immunosuppressive drugs. Here, we show that the interaction between low doses of UVA, the major ultraviolet component of incident sunlight, and 6-TG, a UVA chromophore that is introduced into DNA by one of the most widely prescribed immunosuppressive drugs, causes DNA single- and double-strand breaks (DSB). S phase cells are particularly vulnerable to this DNA breakage and cells defective in rejoining of S-phase DSB are hypersensitive to the combination of low-dose UVA and DNA 6-TG. 6-TG/UVA-induced DNA lesions provoke canonical DNA damage responses involving activation of the ATM/Chk2 and ATR/Chk1 pathways and appropriate cell cycle checkpoints. Higher levels of photochemical DNA damage induce a proteasome-mediated degradation of Chk1 and checkpoint abrogation that is consistent with persistent unrepaired DNA damage. These findings indicate that the interaction between UVA and an immunosuppressant drug causes photochemical DNA lesions, including DNA breaks, and can compromise cell cycle checkpoints. These two properties could contribute to the high risk of sunlight-related skin cancer in long-term immunosuppressed patients.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Al-Tassan N, Chmiel NH, Maynard J, Fleming N, Livingstone AL, Williams GT et al (2002). Inherited variants of MYH associated with somatic G:C->T:A mutations in colorectal tumors. Nat Genet 30: 227–232.
Barnes DE, Lindahl T . (2004). Repair and genetic consequences of endogenous DNA base damage in mammalian cells. Ann Rev Genet 38: 445–47642.
Bickers DR, Athar M . (2006). Oxidative stress in the pathogenesis of skin disease. J Invest Dermatol 126: 2565–2575.
Brem R, Li F, Karran P . (2008). Reactive oxygen species generated by thiopurine/UVA cause irreparable transcription-blocking DNA lesions. Nucleic Acids Res 37: 1951–1961.
Cadet J, Sage E, Douki T . (2005). Ultraviolet radiation-mediated damage to cellular DNA. Mutat Res 571: 3–17.
Cahill MA, Nordheim A, Xu Y-Z . (1996). Crosslinking of SRF to the c-fos SRE CArG box guanines using photo-active thioguanine oligonucleotides. Biochem Biophys Res Commun 229: 170–175.
Caldecott KW . (2003). XRCC1 and DNA strand break repair. DNA Repair 2: 955–969.
Cartwright R, Tambini CE, Simpson PJ, Thacker J . (1998). The XRCC2 DNA repair gene from human and mouse encodes a novel member of the recA/Rad51 family. Nucleic Acids Res 26: 3084–3089.
Cooke MS, Duarte TL, Cooper D, Chen J, Nandagopal S, Evans MD . (2008). Combination of azathioprine and UVA irradiation is a major source of cellular 8-oxo-7,8-dihydro-2′-deoxyguanosine. DNA Repair 7: 1982–1989.
Daehn I, Karran P . (2008). Immune effector cells produce lethal DNA damage in cells treated with a thiopurine. Cancer Res 69: 2393–2399.
Davis MJ . (2004). Reactive species formed on proteins exposed to singlet oxygen. Photochem Photobiol Sci 3: 17–25.
Demple B, DeMott MS . (2002). Dynamics and diversions in base excision DNA repair of oxidized abasic lesions. Oncogene 21: 8926–8934.
Euvrard S, Kanitakis J, Claudy A . (2003). Skin cancers after organ transplantation. N Engl J Med 348: 1681–1691.
Fernandez-Capetillo O, Lee A, Nussenzweig M, Nussenzweig A . (2004). H2AX: the histone guardian of the genome. DNA Repair 3: 959–967.
Grosse Y, Baan R, Straif K, Secretan B, El Ghissassi F, Bouvard V et al. (2009). A review of human carcinogens—Part A: pharmaceuticals. Lancet Onco 10: 13–14.
Grulich AE, vanLeeuwen MT, Falster MO, Vajdic CM . (2007). Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a meta-analysis. Lancet 370: 59–67.
Hoeijmakers JHJ . (2001). Genome maintenance mechanisms for preventing cancer. Nat Genet 411: 366–374.
Karran P, Attard N . (2008). Thiopurines in current medical practice: molecular mechanisms and contributions to therapy-related cancer. Nat Rev Cancer 8: 24–36.
Kasai H, Nishimura S . (1984). Hydroxylation of deoxyguanosine at the C-8 position by ascorbic acid and other reducing agents. Nucleic Acids Res 12: 2137–2145.
Kerzendorfer C, O'Driscoll M . (2009). Human DNA damage response and repair deficiency syndromes: linking genomic instability and cell cycle checkpoint proficiency. DNA Repair 8: 1139–1152.
Koniaras K, Cuddihy AR, Christopoulos H, Hogg A, O'Connell MJ . (2001). Inhibition of Chk1-dependent G2 DNA damage checkpoint radiosensitizes p53 mutant human cells. Oncogene 20: 7453–7463.
Kumar SS, Ghosh A, Devasagayam TP, Chauhan PS . (2000). Effect of vanillin on methylene blue plus light-induced single-strand breaks in plasmid pBR322 DNA. Mutat Res 469: 207–214.
Lam MH, Liu Q, Elledge SJ, Rosen JM . (2004). Chk1 is haploinsufficient for multiple functions critical to tumor suppression. Cancer Cell 6: 45–59.
Lennard L, Thomas S, Harrington CJ, Maddocks JL . (1985). Skin cancer in renal transplant recipients is associated with increased concentrations of 6-thioguanine nucleotide in red blood cells. Br J Dermatol 113: 723–729.
Limoli CL, Ward JF . (1993). A new method for introducing double-strand breaks into cellular DNA. Radiat Res 134: 160–169.
Ljungman M, Hanawalt PC . (1992). Efficient protection against oxidative DNA damage in chromatin. Mol Carcinogenesis 5: 264–269.
Ljungman M, Nyberg S, Nygren J, Eriksson M, Ahnstrom G . (1991). DNA-bound proteins contribute much more than soluble intracellular compounds to the intrinsic protection against radiation-induced DNA strand breaks in human cells. Radiat Res 127: 171–176.
Montaner B, O'Donovan P, Reelfs O, Perrett CM, Zhang X, Xu Y-Z et al. (2007). Reactive oxygen-mediated damage to a human DNA replication and repair protein. EMBO Reports 8: 1074–1079.
O'Donovan P, Perrett C, Zhang X, Montaner B, Xu Y-Z, Harwood CA et al. (2005). Azathioprine and UVA light generate mutagenic oxidative DNA damage. Science 309: 1871–1874.
Ormerod MG . (2000). Flow cytometry—A practical approach. (ed.). Oxford University Press: Oxford, UK, pp 159–177.
Penn I . (1994). The problem of cancer in transplant patients: an overview. Transplant Sci 4: 23–32.
Perrett CM, Walker SL, O'Donovan P, Warwick J, Harwood CA, Karran P et al. (2008). Azathioprine treatment sensitizes human skin to ultraviolet A radiation. Br J Dermatol 159: 198–204.
Shiloh Y . (2001). ATM (ataxia telangiectasia mutated): expanding roles in the DNA damage response and cellular homeostasis. Biochem Soc Trans 29: 661–666.
Smith CC, Archer GE, Forster EJ, Lambert TR, Rees RW, Lynch AM . (1999). Analysis of gene mutations and clastogenicity following short-term treatment with azathioprine in MutaMouse. Environ Mol Mutagen 34: 131–139.
Toyooka T, Ibuki Y, Takabayashi F, Goto R . (2006). Coexposure to benzo[a]pyrene and UVA induces DNA damage: first proof of double-strand breaks in a cell-free system. Environ Mol Mutagen 47: 38–47.
Warren DJ, Andersen A, Slordal L . (1995). Quantitation of 6-thioguanine residues in peripheral blood leukocyte DNA obtained from patients receiving 6-mercaptopurine-based maintenance therapy. Cancer Res 55: 1670–1674.
Yun MH, Hiom K . (2009). CtIP-BRCA1 modulates the choice of DNA double-strand-break repair pathway throughout the cell cycle. Nature 459: 460–463.
Zhang X, Jeffs G, Ren X, O'Donovan P, Montaner B, Perrett CM et al. (2006). Novel DNA lesions generated by the interaction between therapeutic thiopurines and UVA light. DNA Repair 6: 344–354.
Zhang YW, Otterness DM, Chiang GG, Xie W, Liu YC, Mercurio FC et al. (2005). Genotoxic stress targets human Chk1 for degradation by the ubiquitin-proteasome pathway. Mol Cell 19: 607–618.
Acknowledgements
We thank Dr Natalie Attard for some of the experiments with HaCaT cells and Drs John Thacker and Mark O’Driscoll for providing cell lines. The assistance of Cancer Research UK Central Cell Services is also gratefully acknowledged.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Additional information
Supplementary Information accompanies the paper on the Oncogene website
Rights and permissions
About this article
Cite this article
Brem, R., Li, F., Montaner, B. et al. DNA breakage and cell cycle checkpoint abrogation induced by a therapeutic thiopurine and UVA radiation. Oncogene 29, 3953–3963 (2010). https://doi.org/10.1038/onc.2010.140
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/onc.2010.140
Keywords
This article is cited by
-
Oxidative stress induced by UVA photoactivation of the tryptophan UVB photoproduct 6-formylindolo[3,2-b]carbazole (FICZ) inhibits nucleotide excision repair in human cells
Scientific Reports (2017)
-
Kutanes Plattenepithelkarzinom
Der Onkologe (2017)
-
Kutanes Plattenepithelkarzinom
Der Hautarzt (2016)
-
Protein Oxidation and DNA Repair Inhibition by 6-Thioguanine and UVA Radiation
Journal of Investigative Dermatology (2014)